Lantern Pharma (NASDAQ: LTRN) Stock Is Rising In Premarket Today- What’s Driving It Higher?
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company focusing in accelerating the development of precision oncology therapeutics using its RADR Artificial intelligence platform and